Shanghai Pharma Says Hong Kong Listing To Occur On Schedule
This article was originally published in PharmAsia News
Executive Summary
Shanghai Pharmaceuticals Holding said its planned Friday listing on the Hong Kong Stock Exchange would occur as scheduled despite malpractice complaints filed by another Chinese pharma